NICE formally adopts plan for real-world evidence utilisation

• In January, a plan to use a broader range of evidence was formally adopted by NICE
• By using patient records and real-world evidence (such as registries and clinical audits), NICE anticipate improved guidance and sped-up recommendation updates
• While this is intended primarily for health and social care system guidance, it may also be extended to health technology appraisals

Click here to learn more

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

ref: MAR2020LN001